Recruiting now
-
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
Phase 1 · 100 people · 1 site in United States · Recruiting now
-
Radiotherapy Dose Escalation for Non-operative Management of Unresectable Locally Recurrent Rectal Cancer
Not phased · 30 people · 5 sites in Netherlands · Recruiting now
-
Oncolytic Virotherapy to Enhance PReoperative IMmunotherapy Efficacy in Patients With Proficient Mismatch Repair (pMMR) Rectal Cancer
Phase 1 · 20 people · 1 site in Denmark · Recruiting now
-
Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
Phase 1 · 180 people · 8 sites in 6 countries · Recruiting now